SCHEMBL5063642

SCHEMBL5063642

CC(=O)Oc1cc(I)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
GPR35 Q9HC97 7/20 0.43
ALDH1A1 P00352 2/20 0.39
TTR P02766 2/20 0.38
ABCC3 O15438 1/20 0.38
ABCC4 O15439 1/20 0.38
NR1I2 O75469 1/20 0.38
ABCB11 O95342 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
HTR1A P08908 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
RARB P10826 1/20 0.38
COMT P21964 1/20 0.38
SLC6A2 P23975 1/20 0.38
ADORA1 P30542 1/20 0.38
ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8773709 0.83 CYP3A4 (0.48) MEN1KMT2ALMNAHTTALDH1A1
SCHEMBL4005448 0.82 KMT2A (0.52) MEN1KMT2ALMNAHTTGPR35
SCHEMBL823689 0.82 MAPT (0.41) MEN1KMT2ALMNAGPR35ALDH1A1
SCHEMBL11309191 0.77 GPR35 (0.46) MEN1KMT2ALMNAGPR35ALDH1A1
SCHEMBL19071929 0.77 CYP4F2 (0.44) MEN1KMT2ALMNAGPR35ALDH1A1
SCHEMBL377595 0.74 MAPK1 (0.51) MEN1KMT2ALMNAGPR35ALDH1A1
SCHEMBL823830 0.73 ALDH1A1 (0.50) MEN1KMT2ALMNAHTTALDH1A1
SCHEMBL18328830 0.73 GPR35 (0.49) MEN1KMT2AGPR35ALDH1A1TTR
SCHEMBL19425974 0.73 MAPT (0.42) MEN1KMT2ALMNAHTTALDH1A1
SCHEMBL11536853 0.73 GPR35 (0.74) MEN1KMT2ALMNAHTTGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911683-A1 ANTIBODY King's College London (GB) 2021-11-24 EP disclosed
WO-2020148425-A1 ANTIBODY KING'S COLLEGE LONDON (GB) 2020-07-23 WO disclosed
US-20080206754-A1 Method for producing monoclonal antibodies WYETH 2008-08-28 US disclosed
US-7247475-B2 Method for producing monoclonal antibodies WYETH (US) 2007-07-24 US disclosed
US-20060141574-A1 Method for producing monoclonal antibodies WYETH 2006-06-29 US disclosed
US-20060099641-A1 Method of making libraries and anti-ligands BIOINVENT INTERNATIONAL AB (SE) 2006-05-11 US disclosed
US-7011974-B2 Method for producing monoclonal antibodies WYETH (US) 2006-03-14 US disclosed
EP-1470225-A1 METHOD OF MAKING LIBRARIES OF ANTI-LIGANDS Bioinvent International AB (SE) 2004-10-27 EP disclosed
US-20030153039-A1 Method for producing monoclonal antibodies WYETH (US) 2003-08-14 US disclosed
WO-2003064648-A1 METHOD OF MAKING LIBRARIES OF ANTI-LIGANDS BIOINVENT INTERNATIONAL AB (SE) 2003-08-07 WO disclosed
US-6475787-B1 Method for producing monoclonal antibodies WYETH 2002-11-05 US disclosed
US-6027735-A IMPROVING NUTRIENT UTILIZATION IN AN ANIMAL OR HUMAN BY IMMUNIZING ORALLY OR PARENTERALLY WITH AN ANTIGEN TO INITIATING DIGESTION, STIMULATING THE SECRETION OF DIGESTIVE ACIDS AND ENZYMES, INCREASING THE BLOOD FLOW AND STIMULATING EFFEM GMBH (DE) 2000-02-22 US disclosed
US-5965605-A ANTAGONIZING INTERACTION BETWEEN IMMUNOGLOBIN E AND ITS RECEPTOR FC.EPSILON.RI ON SURFACE OF MAMMALIAN CELL BY ADMINISTERING ANTAGONIZING AMOUNT OF TETRACYCLIC COMPOUND TO PREVENT ALLERGIC RESPONSES HESKA CORPORATION (US) 1999-10-12 US disclosed
US-5725861-A Products and processes for gastric cascade and gastrointestinal disorder treatment with same EFFEM GMBH (DE) 1998-03-10 US disclosed
WO-1997040033-A1 INHIBITION OF THE BINDING OF HUMAN IGE TO ITS RECEPTOR BY TETRACYCLIC COMPOUNDS FOR THE ALLEVIATION OF IGE-MEDIATED IMMUNE RESPONSE LEXIGEN PHARMACEUTICALS CORP. (US) 1997-10-30 WO disclosed
EP-0483194-B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST DYNAL AS (NO) 1996-04-17 EP disclosed
US-5348876-A DNA molecules and codes with polypeptide sequences DYNAL AS (NO) 1994-09-20 US disclosed
EP-0483194-A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST. DYNAL AS (NO) 1992-05-06 EP disclosed
WO-1991001335-A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST DYNAL A.S. (NO) 1991-02-07 WO disclosed
EP-0267779-A2 Human pleiotropic immune factor and muteins thereof Schering Biotech Corporation (US) 1988-05-18 EP disclosed